中国病理生理学会危重病医学专业委员会 |

[ICU Management & Practice]: 提高英格兰危重新冠肺炎患者的生存率

Original Investigation Caring for the Critically Ill PatientSeptember 2, 2020 Effect of Hydrocortisone on 21-Day Mortality or Respiratory Support Among Critically Ill Patients With COVID-19: A Randomized Clinical Trial Pierre-François Dequin, Nicholas Heming, Ferhat Meziani, et al JAMA. Publ...

[PulmCCM]: 新冠肺炎胸部CT

2020年06月04日 ⁄ 时讯速递, 进展交流

An Illustrated Guide to the Chest CT in COVID-19 Mar 16 2020 Jon-Emile S. Kenny MD [@heart_lung] with illustrations by Carla M. Canepa MD [@_carlemd_] Background The coronavirus moniker originates from the appearance of the virus under the electron microscope – protein peplomers radiating fr...

[JAMA发表论文]：高血糖强化

2019年08月06日 ⁄ 时讯速递, 进展交流

Original Investigation | July 23/30, 2019 Intensive vs Standard Treatment of Hyperglycemia and Functional Outcome in Patients With Acute Ischemic Stroke: The SHINE Randomized Clinical Trial Karen C. Johnston, Askiel Bruno, Qi Pauls, et al JAMA. 2019;322(4):...

[JAMA述评]：脓毒症诊疗的政

2019年08月05日 ⁄ 研究点评, 进展交流

Editor's Note July 16, 2019 Government Regulation of Sepsis Care Demetrios N. Kyriacou JAMA. 2019;322(3):250-251. doi:10.1001/jama.2019.9230 每年全球约有3000万脓毒症患者，且导致约600万患者死亡。尽管不断提出新的治疗手段，但是，过去数十年间脓毒症相关病死率的下降主要源于早期识别以及包括...

0℃

研究点评, 进展交流

[ICU Management & Practice]: 提高英格兰危重新冠肺炎患者的生存率

2021年05月16日 ⁄ 研究点评, 进展交流

2021年05月16日

Improving Survival of Critical Care Patients With COVID-19 in England Data from the UK suggests that there has been an improvement in the survival of hospitalised patients with COVID-19 in recent months. Case-fatality rate of hospitalised patients declined from 6% in April 2020 to 1.5% by July 2020. A possible explanation for this shift may be the fact that there has been a shift in the demographics of people admitted with COVID-19. Patient...

阅读全文